399 related articles for article (PubMed ID: 15037971)
41. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
[TBL] [Abstract][Full Text] [Related]
42. Synergistic antimyeloma effects of zoledronate and simvastatin.
Schmidmaier R; Simsek M; Baumann P; Emmerich B; Meinhardt G
Anticancer Drugs; 2006 Jul; 17(6):621-9. PubMed ID: 16917207
[TBL] [Abstract][Full Text] [Related]
43. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M
Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374
[TBL] [Abstract][Full Text] [Related]
44. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
46. Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.
Gangoiti MV; Cortizo AM; Arnol V; Felice JI; McCarthy AD
Eur J Pharmacol; 2008 Dec; 600(1-3):140-7. PubMed ID: 18973752
[TBL] [Abstract][Full Text] [Related]
47. Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Nishisho T; Hanaoka N; Endo K; Takahashi M; Yasui N
Orthopedics; 2011 Jul; 34(7):e312-5. PubMed ID: 21717996
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
Yang T; Zheng XF; Li M; Lin X; Yin QS
Asian Pac J Cancer Prev; 2013; 14(9):5379-83. PubMed ID: 24175830
[TBL] [Abstract][Full Text] [Related]
49. A flow cytometric study on giant cell tumor of bone.
Guo W; Ren X; Feng C
Chin Med J (Engl); 1996 Feb; 109(2):134-7. PubMed ID: 8758338
[TBL] [Abstract][Full Text] [Related]
50. Giant cell tumor of bone: a unique paradigm of stromal-hematopoietic cellular interactions.
Robinson D; Einhorn TA
J Cell Biochem; 1994 Jul; 55(3):300-3. PubMed ID: 7962160
[TBL] [Abstract][Full Text] [Related]
51. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
Balke M; Campanacci L; Gebert C; Picci P; Gibbons M; Taylor R; Hogendoorn P; Kroep J; Wass J; Athanasou N
BMC Cancer; 2010 Aug; 10():462. PubMed ID: 20799989
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone.
Mak IW; Cowan RW; Popovic S; Colterjohn N; Singh G; Ghert M
Bone; 2009 Aug; 45(2):377-86. PubMed ID: 19422937
[TBL] [Abstract][Full Text] [Related]
53. Relationship between binuclear and multinuclear cells in giant cell tumor of bone.
Kusuzaki K; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(4):2463-7. PubMed ID: 10953311
[TBL] [Abstract][Full Text] [Related]
54. N-acetyl cysteine inhibits human signet ring cell gastric cancer cell line (SJ-89) cell growth by inducing apoptosis and DNA synthesis arrest.
Li J; Tu HJ; Li J; Dai G; Dai YC; Wu Q; Shi QZ; Cao Q; Li ZJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):769-74. PubMed ID: 17700262
[TBL] [Abstract][Full Text] [Related]
55. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
Montague R; Hart CA; George NJ; Ramani VA; Brown MD; Clarke NW
Eur Urol; 2004 Sep; 46(3):389-401; discussion 401-2. PubMed ID: 15306113
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.
Singh US; Shankar R; Kumar A; Trivedi R; Chattopadhyay N; Shakya N; Palne S; Gupta S; Hajela K
Bioorg Med Chem; 2008 Sep; 16(18):8482-91. PubMed ID: 18752963
[TBL] [Abstract][Full Text] [Related]
57. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
[TBL] [Abstract][Full Text] [Related]
58. Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells.
Tang T; Zhang G; Lau CP; Zheng LZ; Xie XH; Wang XL; Wang XH; He K; Patrick Y; Qin L; Kumta SM
Biomed Mater; 2011 Feb; 6(1):015004. PubMed ID: 21205994
[TBL] [Abstract][Full Text] [Related]
59. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
60. Binuclear cells induced by acridine orange in giant cell tumor of bone.
Kusuzaki K; Takeshita H; Murata H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5A):3013-7. PubMed ID: 11062716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
